NUTEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Nutex Health Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Nutex Health Inc. following a class action complaint filed on August 22, 2025, concerning alleged breaches of fiduciary duties by the company's board of directors during the class period from August 8, 2024, to August 14, 2025 [1][2]. Summary by Sections Allegations - The complaint alleges that Nutex's management made materially false and misleading statements regarding the company's business and operations, including: - Engaging in a scheme to defraud insurance companies through HaloMD, leading to unsustainable revenues [2]. - Overstating the remediation of material weaknesses in internal controls over financial reporting [2]. - Improperly accounting for stock-based compensation obligations as equity instead of liabilities [2]. - Increased risk of failing to timely file financial reports with the SEC due to these issues [2]. - Overall, the company's business and financial prospects were overstated, making public statements materially false and misleading [2]. Next Steps for Investors - Long-term stockholders of Nutex are encouraged to contact Bragar Eagel & Squire for more information regarding their rights and potential claims related to the allegations [3]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various complex litigations across state and federal courts [4].